Shares of Ajanta Pharma on Wednesday shot up by 20 per cent to touch the upper circuit limit, after the company reported 75.95 per cent increase in net profit for the third quarter ended December 31, 2012.

Following the strong set of numbers, shares of the company soared 19.99 per cent to Rs 490.65 —— its upper circuit limit on the BSE.

At NSE, the stock jumped 20 per cent to Rs 491.45.

On the volume front, 5.62 lakh shares of the company changed hands on the BSE, while over 11 lakh shares were traded on NSE.

Ajanta Pharma today reported 75.95 per cent increase in net profit to Rs 32.57 crore for the quarter ended December 31, 2012, mainly on robust sales.

The company had posted a net profit of Rs 18.51 crore for the corresponding period previous fiscal.

Net sales of the company rose to Rs 225.68 for the quarter under review from Rs 164.52 crore for the same period last fiscal.

(This article was published on January 23, 2013)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.